Vena caval filter to prevent pulmonary embolism: experimental study. Work in progress.

@article{Gnther1985VenaCF,
  title={Vena caval filter to prevent pulmonary embolism: experimental study. Work in progress.},
  author={Rolf W. G{\"u}nther and Hans H. Schild and A Fries and Stephan St{\"o}rkel},
  journal={Radiology},
  year={1985},
  volume={156 2},
  pages={
          315-20
        }
}
A new inferior vena caval filter was tested in an experimental series of 23 dogs and in an in vitro study. The filter consists of a pliable basket and anchoring legs made of stainless steel. It can be inserted percutaneously in an antegrade or retrograde fashion through a 10-F Teflon catheter and can be retrieved with a snare or forceps. The filter is self-orienting in the inferior vena cava, becomes securely the inferior vena cava, becomes securely fixed to the wall, and has exhibited no… 

New retrievable percutaneous vena cava filter: Experimentalin vitro andin vivo evaluation

A new retrievable percutaneous vena cava filter that seems to be suitable for temporary or permanent protection against pulmonary embolism was tested in vitro and in vivo in 15 foxhounds.

Günther vena caval filter: clinical appraisal.

Percutaneous Retrieval of the Tulip Vena Cava Filter: Feasibility, Short- and Long-Term Changes. An Experimental Study in Dogs

The Tulip filter allows percutaneous insertion and retrieval up to 14 days after insertion, suggesting that it may be useful for either permanent or temporary prophylaxis against pulmonary embolism.

Inferior Vena Cava Filters: Types, Placement, and Efficiency

Although anticoagulation therapy has reduced the incidence of pulmonary thromboembolism, the disease remains an important cause of morbidity and mortality in hospitalized patients and interruption of the inferior vena cava (IVC) may be lifesaving.

In Vitro Assessment of the DIL and Greenfield Vena Cava Filter System

The Greenfield filter has gained most widespread clinical acceptance and has been reported to have prevented complications like thrombosis at the insertion site after using filters.

Clinical Experience with Temporary Vena Cava Filters

Although this experience is small, temporary filter placement is safe and effective for short-term prevention of pulmonary emboli even in older patients or those with malignant disease.

First clinical results with a new caval filter

A new percutaeous inferior venacaval filter was used in 15 patients and one patient died of recurrent embolism despite filter protection, and Heparin coating of the filter is under evaluation.

Vena Cava Filters

An analysis of 14 studies that assessed the risk of recurrent pulmonary embolism suggests that, although anticoagulation remains the principal method of prophylaxis and treatment of pulmonary emboli, it does not completely eliminate recurrent emboli.

In vitro evaluation of caval filters

While filters performed suboptimally, strengthening the anchoring struts of the Günther filter would result in a secure, effective filter.